Harnessing Cytomegalovirus DNAemia and CMV-Specific Cell-Mediated Immunity in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients
Journal of Korean Medical Science · 2026
DOI: 10.3346/jkms.2026.41.e86 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Korean Medical Science, 2026. Verfasst von Sanghoon Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Cytomegalovirus, Immunity, Cellular. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Asan Institute for Life Sciences.
Abstract (Originalsprache)
BACKGROUND: Recovery via cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) in pediatric hematopoietic stem cell transplantation (HSCT) recipients is associated with a lower incidence of significant CMV DNAemia and disease. This study aimed to determine whether early post-HSCT CMI monitoring could predict CMV infection outcomes and identify factors that influence CMI recovery. METHODS: Pediatric patients (≤ 19 years) undergoing allogeneic HSCT at Asan Medical Center Children's Hospital between August 2018 and February 2020 were prospectively enrolled. CMV-specific CMI was assessed using the enzyme-linked immunospot assay for phosphoprotein 65 (pp65) or immediate-early protein 1 (IE-1) antigens at pre-transplantation, and 1 and 3 months post-transplantation. Plasma CMV polymerase chain reaction monitoring was conducted regularly, and the incidence of CMV DNAemia and CMV disease was evaluated over a two-year follow-up period. RESULTS: Of the 55 enrolled pediatric recipients, CMV DNAemia occurred in 74.5%, with 21.8% of cases progressing to significant CMV DNAemia. Cumulative CMI recovery rates at 3 months were 61.8% for pp65 and 43.6% for IE-1. Recipients with a cumulative recovery of pp65-specific CMI exhibited a significantly lower incidence of significant CMV DNAemia and CMV disease. In contrast, the cumulative recovery of IE-1-specific CMI was not associated with CMV outcomes. In the multivariate analysis, haploidentical donor status and post-HSCT CMV DNAemia were independently associated with impaired cumulative recovery of both pp65- and IE-1-specific CMI. CONCLUSION: Monitoring pp65-specific CMI recovery within three months post-HSCT is valuable for predicting significant CMV infection in pediatric recipients. Haploidentical HSCT recipients demonstrated impaired CMI recovery, highlighting the need for careful monitoring and tailored prophylactic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Pediatrics, Chonnam National University Hospital, Gwangju, Korea.
- Department of Pediatrics, Chosun University Hospital, Gwangju, Korea.
- Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Korea. entier@amc.seoul.kr.
ORCID-Profile: Sanghoon Lee, Gahee Kim, Jung Hwa Kim, Eun Seok Choi, Sung Han Kang, Hyery Kim, Kyung-Nam Koh, Ho Joon Im, Jina Lee
Förderung
- Asan Institute for Life Sciences
Zitieren
APA
Lee, S., Kim, G., Kim, J. H., Choi, E. S., Kang, S. H., Kim, H., Koh, K. N., Im, H. J., & Lee, J. (2026). Harnessing Cytomegalovirus DNAemia and CMV-Specific Cell-Mediated Immunity in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2026.41.e86
Vancouver
Lee S, Kim G, Kim JH, Choi ES, Kang SH, Kim H, et al. Harnessing Cytomegalovirus DNAemia and CMV-Specific Cell-Mediated Immunity in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients. Journal of Korean Medical Science. 2026. doi:10.3346/jkms.2026.41.e86
BibTeX
@article{Lee2026,
author = {Lee, Sanghoon and Kim, Gahee and Kim, Jung Hwa and Choi, Eun Seok and Kang, Sung Han and Kim, Hyery and Koh, Kyung-Nam and Im, Ho Joon and Lee, Jina},
title = {Harnessing Cytomegalovirus DNAemia and CMV-Specific Cell-Mediated Immunity in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients},
journal = {Journal of Korean Medical Science},
year = {2026},
doi = {10.3346/jkms.2026.41.e86}
}
EUVIMED